Baldwin to go private in $7.7B cash deal at $32.50 a share
Take-private at a big cash premium Sequence Holdings and Michael Dell's family office agreed to buy Baldwin for $7.7 billion, paying $32.50 a share in cash — about an 88% premium to the price before deal talks surfaced. That fixed cash price is why the stock jumped and now trades near $32, close to the offer.
The take-private is the single event that now sets BWIN's price.
Buyers committed, no financing condition The buyers signed a definitive deal with no financing condition, and the board unanimously approved it. Eligible employees can roll part of their stock into the private company. That structure makes the $32.50 payout look more certain, supporting the shares near the offer price.
Deal certainty is what keeps the stock pinned near the cash offer.
Little upside left; closing still needs approvals With shares around $31.89 versus the $32.50 cash offer, almost all the gain is already priced in. Shareholders must still vote and regulators must clear the deal, expected to close in early 2027, so any delay or rejection is the main risk now.
It is the real counterweight: the easy money has been made and completion risk remains.
Solid profit growth, but weak organic sales and a net loss Baldwin entered the deal with revenue up 30% and adjusted EBITDA up 37%, yet organic revenue rose only 2% and it posted a $56 million GAAP net loss. The buyers are paying about 20 times trailing adjusted EBITDA, a full price that reflects these mixed results.
It explains the operating backdrop behind the price the buyers agreed to pay.